ankylosing spondylitis
New Indication Granted to Rinvoq for Active Ankylosing Spondylitis
The FDA granted a new indication to upadacitinib for the treatment of adults with active ankylosing spondylitis who ...
MAY 13, 2022
FDA Approves Hadlima Biosimilar for RA, Other Inflammatory Condition
Hadlima was approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic ...
AUGUST 27, 2019
FDA Panel Recommends Approval for Second Biosimilar
Based on the biological similarity o the innovator product, the panel endorsed its use for the all the indications ...
FEBRUARY 10, 2016
Load more